Russell Investments Group’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Russell Investments Group’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,240	Closed	-$15K	–	3001
2022 Q2	$15K	Hold	9,240	–	–	﹤0.01%	2823
2022 Q1	$27K	Buy	+9,240	New	+$32.4K	﹤0.01%	2667
2019 Q4	–	Sell	-6,909	Closed	-$10K	–	3154
2019 Q3	$10K	Sell	6,909 -178	-3%	-$389	﹤0.01%	2977
2019 Q2	$20K	Buy	7,087 +182	+3%	+$724	﹤0.01%	2797
2019 Q1	$33K	Buy	6,905 +3,405	+97%	+$16.8K	﹤0.01%	2846
2018 Q4	$15K	Buy	+3,500	New	+$27K	﹤0.01%	2879

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Russell Investments Group's SURF Position: Q3 2022 in Review

Russell Investments Group sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2022, closing a stake of 9,240 shares — an estimated $15K sold.

Russell Investments Group first reported a position in SURF in Q4 2018 and held it in 6 quarters. The position peaked at $33K in Q1 2019. 79 funds tracked by Wall St. Rank hold SURF as of Q3 2022.

Russell Investments Group reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Russell Investments Group sold 9,240 Surface Oncology, Inc. Common Stock shares in Q3 2022, an estimated $15K.
Russell Investments Group first reported a position in Surface Oncology, Inc. Common Stock in Q4 2018 and held it in 6 quarters.
Russell Investments Group's Surface Oncology, Inc. Common Stock position peaked at $33K in Q1 2019.
79 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2022.

Based on Russell Investments Group's 13F filing for Q3 2022, filed 4 Nov 2022.